Liquid pharmaceutical formulations of palonosetron

  • US 9,439,854 B2
  • Filed: 07/07/2015
  • Issued: 09/13/2016
  • Est. Priority Date: 01/30/2003
  • Status: Active Grant
First Claim
Patent Images

1. A formulation for reducing emesis or reducing the likelihood of emesis in a human, the formulation comprising a pharmaceutical single-use, unit-dose, sterile aqueous intravenous solution comprising palonosetron or a pharmaceutically acceptable salt thereof in a concentration of 0.05 mg/mL based on the weight of the palonosetron free base and in a volume of from 1 mL to 5 mL.

View all claims

    Thank you for your feedback